Donepezil for dementia due to Alzheimer's disease-Reference-Cited by-同舟云学术

Donepezil for dementia due to Alzheimer's disease

Published:2018-06-18 Issue:6 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Birks Jacqueline S¹,Harvey Richard J²

Affiliation:

1. University of Oxford; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences; Botnar Research Centre, Windmill Road Oxford UK OX3 7LD

2. Deakin University and Private Practice; Medical School; c/o Telepsychiatrist Online PO Box 117 North Geelong Victoria Australia 3215

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001190.pub3/epdf/full

Reference301 articles.

1. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial;AD2000 Collaborative Group;Lancet,2004

2. Bentham P Gray R Hill R Sellwood E Courtney C Twelve week response to cholinesterase inhibitors dose not predict future benefit the AD2000 trial experience The 8th conference on Alzheimer's disease and related disorders, July 20-25, 2002, Stockholm, Sweden 2002 337

3. Lendon CL Determination of responses to anticholinesterase therapy in the treatment of Alzheimer's disease 8th International Conference on Alzheimer's Disease and Related Disorders; 2002 July 20-25, Stockholm, Sweden: Abstract No 1287 2002

4. Roberts N A reliable assessment of the efficacy and safety of donepezil and aspirin in Alzheimer's disease (AD2000) National Research Register 2001

5. AD2000: donepezil in Alzheimer's disease;Schneider;Lancet,2004

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oscillatory characteristics of resting-state magnetoencephalography reflect pathological and symptomatic conditions of cognitive impairment;Frontiers in Aging Neuroscience;2024-01-30

2. How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer’s disease?;Expert Opinion on Emerging Drugs;2024-01-09

3. Network pharmacology-based analysis of Jin-Si-Wei on the treatment of Alzheimer's disease;Journal of Ethnopharmacology;2024-01

4. The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment;Neurology, Neuropsychiatry, Psychosomatics;2023-12-16

5. Early intervention and adding effective doses of EGb761 like Ginkgo extract slow down dementia progression: insights to the neurovascular unit;Frontiers in Neurology;2023-12-13